F-Prime is a global venture capital firm based in Cambridge, Massachusetts, and operates as the venture arm of Fidelity. The firm invests across healthcare and technology, with a particularly strong reputation in company creation, therapeutics, and long-horizon scientific innovation.

Its portfolio includes major life science companies and reflects deep conviction in complex modalities and science-heavy company building. F-Prime is highly relevant for neurotech companies at the intersection of neuroscience, therapeutics, diagnostics, and platform biology, especially where strong scientific support and long-term capital are needed.

The firm invests internationally, with major presence in the United States, London, and other core innovation hubs. It matters most for neuro-focused companies aiming to build large, clinically significant platforms rather than narrow point solutions.